MusclePharm Corporation Stock

Stocks

23-10-18	Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	CI
23-10-09	FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	CI
23-10-03	Motion for Asset Sale Approved for MusclePharm Corporation	CI
23-09-26	FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	CI
23-09-08	Stalking Horse Agreement Filed by MusclePharm Corporation	CI
23-08-31	Musclepharm Corporation Announces Resignation of Paul Karr as Director	CI
23-08-28	Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	CI
23-08-28	First Amended Disclosure Statement Approved for MusclePharm Corporation	CI
23-08-17	Bidding Procedure Approved for MusclePharm Corporation	CI
23-07-19	Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	CI
23-06-19	First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	CI
23-05-26	Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	CI
23-05-12	Motion for Asset Sale Filed by MusclePharm Corporation	CI

23-06-28	SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud	AQ
22-09-29	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ
22-09-19	MusclePharm : Accelaration/Increase of Financial Obligation - Form 8-K	PU
22-09-19	MUSCLEPHARM CORP : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement (form 8-K)	AQ
22-08-23	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ

Manager	Title	Age	Since
Tyler Jeffrey Dillashaw PRN	Corporate Officer/Principal	-	2021-09-30
Jason Keenan PRN	Corporate Officer/Principal	-	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
3/29/22	White Winston Select Asset Funds LLC	Sell	Company	626,826	1.8775%
12/21/21	Sabina Rizvi	Free	Chairperson	1,811,000	5.4244%
4/1/21	Sabina Rizvi	Other	President & CFO	0	0%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MUSCLEPHARM CORPORATION	-.--%	-.--%	-	-	33
CHURCHILL CAPITAL CORP XI	-6.71%	-9.82%	-	-	813M
CENTIEL AG	+10.67%	+2.25%	+327.06%	-67.30%	668M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	0.00%	-0.10%	-	-	645M
CHURCHILL CAPITAL CORP XII	-0.74%	0.00%	-	-	595M
BAIN CAPITAL GSS INVESTMENT CORP.	+0.59%	+0.59%	-	-	602M
CANTOR EQUITY PARTNERS IV, INC.	-0.10%	-0.29%	-	-	594M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.26%	-0.86%	-	-	569M
CHURCHILL CAPITAL CORP XIII	-0.10%	-0.38%	-	-	507M
Average	+0.98%	-1.94%	+327.06%	-67.30%	624.05M
Weighted average by Cap.	+1.15%	-2.33%	+327.06%	-67.30%